Brookfield Corp’s Omnicell OMCL Stock Holding History

Brookfield Corp’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,500	Closed	-$1.62M	–	617
2021 Q1	$1.62M	Buy	12,500 +2,500	+25%	+$321K	0.01%	311
2020 Q4	$1.2M	Buy	+10,000	New	+$981K	0.01%	352

Other funds holding OMCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Brookfield Corp's OMCL Position: Q2 2021 in Review

Brookfield Corp sold out of Omnicell (OMCL) in Q2 2021, closing a stake of 12,500 shares — an estimated $1.62M sold.

Brookfield Corp first reported a position in OMCL in Q4 2020 and held it in 2 quarters. The position peaked at $1.62M in Q1 2021. 377 funds tracked by Wall St. Rank hold OMCL as of Q2 2021.

Brookfield Corp reported no remaining Omnicell position as of Q2 2021 after selling out during the quarter.
Brookfield Corp sold 12,500 Omnicell shares in Q2 2021, an estimated $1.62M.
Brookfield Corp first reported a position in Omnicell in Q4 2020 and held it in 2 quarters.
Brookfield Corp's Omnicell position peaked at $1.62M in Q1 2021.
377 funds tracked by Wall St. Rank held Omnicell as of Q2 2021.

Based on Brookfield Corp's 13F filing for Q2 2021, filed 17 Aug 2021.